770
Participants
Start Date
November 12, 2019
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
High flow Oxygenation
Interventional group: All patients included in this group will receive a continuous heated and humidified high-flow (30 to 60 l/min) oxygenation with a nasal cannula for 48 hours. Initially, flow rate will be started at 50 l/min with a FiO2 at 50%. According to the protocol, flow rate and FiO2 will be titrated on SpO2 and respiratory tolerance. Weaning and failure of high-flow oxygenation are described in detail in the study protocol.
Standard oxygen
Control group: All patients included in this group will receive a low flow oxygenation (flow rate \< 15 l/min) with nasal cannula (flow rate ≤ 6 l/min) or non-rebreathing mask (flow rate ≥ 7 l/min).
La Timone Hospital (AP-HM), Marseille
Chartres Hospital, Chartres
Centre Hospitalier de Cornouaille, Quimper
CHU de Brest, Brest
CHRU de Montpellier, Montpellier
Rennes, university Hospital, Rennes
CHBA de Vannes, Vannes
Centre Hospitalier de Bretagne Sud, Lorient
CHRU de la Pitié-Salpétrière, Paris
HIA Percy, Clamart
Angers university hospital, Angers
Dreux hospital, Dreux
Le Mans hospital, Le Mans
Marseille university horpital, Marseille
Morlaix hospital, Morlaix
Nantes university hospital, Nantes
Kremlin Bicêtre university hospital (APHP), Paris
Tours university hospital, Tours
University Hospital, Brest
OTHER